Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion type Assertion NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_head.
- NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_provenance.
- NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion evidence source_evidence_literature NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_provenance.
- NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion SIO_000772 12240753 NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_provenance.
- NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion wasDerivedFrom befree-20150227 NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_provenance.
- NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion wasGeneratedBy ECO_0000203 NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_provenance.